Summary of the virtual conference held on October 16, 2025
16/10/2025 – AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
AB Science webcast of October 16, 2025
16/10/2025 – Presentation of the AB Science webcast held on October 16, 2025